Statistics on Biotechnology Use  
Results by fields of operation
Business Sector Biotechnology indicators by branch of activity. 
Unidades: specified in variables

,Total Companies,Services,Industry and Construction,Agriculture,
No. of companies carrying out R&D in Biotechnology,1.348,818,427,103,
%Companies according to biotechnology used: Genetic code,31,39,9,15,9,22,9,
%Companies according to biotechnology used: Functional units,38,4,42,8,33,9,22,2,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,21,7,26,3,13,5,19,1,
%Companies according to biotechnology used: Bioprocesses,50,3,40,74,4,33,
%Companies according to biotechnology used: Sub-cellular organisms,8,2,11,1,4,3,2,
%Companies according to biotechnology used: Bio-computing,24,1,34,1,9,2,6,9,
%Companies according to biotechnology used: Nanobiotechnology,11,8,16,2,5,8,1,
%Companies according to biotechnology used: Other,16,4,18,3,7,8,36,9,
Companies in which biotechnology activities are: Main and/or exclusive,661,529,109,23,
Companies in which biotechnology activities are: A secondary line of business,188,105,69,14,
Companies in which biotechnology activities are: A tool necessary for production,500,184,250,66,
%Company by field(s) of ultimate application of biotechnology use: Human Health,45,8,61,6,25,5,5,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,15,3,16,4,10,9,24,2,
%Company by field(s) of ultimate application of biotechnology use: Food products,31,5,21,51,7,32,1,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,23,7,20,2,21,3,60,7,
%Company by field(s) of ultimate application of biotechnology use: Environment,15,5,16,1,15,1,13,1,
%Company by field(s) of ultimate application of biotechnology use: Industry,13,4,14,2,14,2,4,
Personnel in R&D in biotechnology (no. of persons),15.744,9.783,4.929,1.032,
Personnel in R&D in biotechnology (no. of persons): Research personnel,8.380,6.054,2.067,259,
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel,7.364,3.729,2.862,773,
Personnel in R&D in biotechnology (no. of persons). Women,8.725,5.567,2.720,438,
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel,4.521,3.331,1.085,104,
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel,4.204,2.236,1.635,334,
Personnel in R&D in biotechnology (FTE),11.523,2,7.360,5,3.555,3,607,5,
Personnel in R&D in biotechnology (FTE): Research personnel,6.341,6,4.606,5,1.557,7,177,3,
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel,5.181,6,2.753,9,1.997,6,430,2,
Personnel in R&D in biotechnology (FTE). Women,6.552,7,4.194,8,2.088,7,269,2,
Personnel in R&D in biotechnology (FTE). Women: Research personnel,3.464,4,2.518,3,872,8,73,3,
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel,3.088,3,1.676,5,1.215,9,195,9,
Internal expenditure on R&D (thousands of euros),1.037.887,632.044,365.151,40.692,
1) By nature of the expense: Current expenses,939.471,572.886,329.570,37.015,
1.1) Remuneration to research personnel,321.525,220.159,91.852,9.514,
1.2) Remuneration to technical and auxiliary personnel,194.656,95.001,86.840,12.816,
1.3) Other current expenses,423.290,257.726,150.878,14.686,
2) By nature of the expense: Capital expenses,98.416,59.158,35.581,3.677,
2.1) Land and buildings,10.150,6.669,2.905,577,
2.2) Equipment and instruments,72.538,40.536,30.157,1.845,
2.3) Acquisition of specific R&D software,5.713,3.849,1.726,138,
2.4) Otros productos de propiedad intelectual específicos para I+D,10.015,8.104,794,1.117,
1.1) By origin of the funds: Own funds,711.037,360.440,315.867,34.730,
1.2) By origin of the funds: From companies,121.595,109.172,7.824,4.600,
1.3) By origin of the funds: Public Administration funds,107.422,91.468,14.662,1.292,
1.4) By origin of the funds: From Universities,192,182,11,0,
1.5) By origin of the funds: From non profit private institutions,10.756,10.585,171,0,
1.6) By origin of the funds: Foreign funds,86.884,60.196,26.617,70,
Purchase of R&D services in biotechnology (thousands of euros),145.440,75.379,68.977,1.085,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,95.870,52.783,42.361,726,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,49.570,22.595,26.616,359,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,39,8,48,3,26,8,25,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,12,5,12,2,13,6,10,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,18,5,19,9,16,4,16,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,11,2,11,4,10,8,11,9,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,15,6,18,11,7,12,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,16,5,19,9,10,7,13,9,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,16,1,16,3,15,7,15,8,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,40,43,1,34,9,37,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,53,9,57,8,46,9,51,9,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,21,5,22,1,19,26,8,
% Companies with income of an international origin related to biotechnological activities,22,2,24,1,22,3,7,
% Turnover representing income of an international origin related to biotechnological activities,1,9,5,8,1,5,2,4,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,65,5,60,2,67,5,68,3,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,34,5,39,8,32,5,31,7,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,86,3,84,87,3,85,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,12,2,11,9,12,6,0,
% Income of an international origin related with activities according to the classification: Operating source abroad,1,1,3,8,0,1,0,
% Income of an international origin related with activities according to the classification: Other,0,4,0,3,0,15,
Notas:
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute